Medtronic Gaining Share in the US Drug-Eluting Stent Market
publication date: May 22, 2012
Medtronic posted strong fiscal fourth-quarter results and offered a solid outlook for its fiscal 2013. We're big fans of the medical device maker's dividend-growth profile and expect the company to continue to return cash to shareholders.
To gain access to the members only content, click here to subscribe.
You will be given immediate access to premium content on the site.